| Name | Title | Contact Details |
|---|
BNCCORP, Inc. (OTCQB: BNCC), headquartered in Bismarck, N.D., is a registered bank holding company dedicated to providing banking and wealth management services to businesses and consumers in its local markets. The Company operates community banking and wealth management businesses in Arizona, Minnesota and North Dakota. BNC also conducts mortgage banking from locations in the Midwest. The Company offers financial products and services to meet the financial needs of its current customers, and potential customers, in the markets it serves.
AIA Singapore is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group in the world and the second largest life insurance company in the world by market capitalisation. As a leading company in Singapore, AIA Singapore takes a leadership role in contributing to the nations social and economic progress by enabling families to live healthier, longer, better lives. Together with one of Singapores biggest and most committed team of AIA Financial Services Consultants, our dedicated staff are united in continually pursuing this goal. With a focus on providing excellent service to our customers, we partner with individuals, families and corporates in Singapore for a brighter and more prosperous future for all. Committed to the vision of being the pre-eminent life insurer in the country, admired for excellent service and best practices, AIA Singapore conducts our business according to an operating philosophy of "Doing the Right Thing, in the Right Way, with the Right People." Any personal information supplied by you in connection with your use of this social media platform may be collected, stored, handled, used and deleted in accordance with the AIA Singapore Privacy Policy available at http://www.aia.com.sg/en/index/personal-data-policy.html
Manufacturing and sale of industrial precision balls, rollers, cages and sheet metal parts used for bearing and other applications. Manufacturing and sale of ball screws, and large scale blowers.
Continental Automotive Trading Italia Srl ha sede a Cinisello Balsamo (MI) e fa parte del Gruppo Continental, che con i marchi VDO, ATE e GALFER è tra i principali fornitori mondiali di elettronica e meccatronica per il settore automotive. Presso la sede di Cinisello Balsamo è presente anche un servizio di assistenza e formazione altamente qualificato. Continental Automotive Trading Italia Srl si avvale di una rete capillare di vendita estesa su tutto il territorio nazionale. VDO – Tachigrafi, Telematica e Servizi VDO è leader globale nel mercato delle soluzioni per tachigrafi. Il DTCO (tachigrafo digitale) di VDO e i suoi componenti offrono ad autisti, a gestori di flotte e autorità una soluzione conforme alla normativa, affidabile e tecnologicamente avanzata, che definisce gli standard per prestazioni allavanguardia, facilità dutilizzo e sicurezza dei dati. ATE Il marchio ATE si occupa di tutto ciò che riguarda i ricambi per freni, in particolare i componenti di usura ed idraulici per ricambi di qualità o per interventi di integrazione ed ottimizzazione finalizzati a un maggiore livello di sicurezza e divertimento alla guida. Ricerca ed evoluzione costanti, esperienze nelle grandi serie e tradizione negli sport motoristici rendono i nostri prodotti per la componentistica automotive fra i più venduti. GALFER Le pastiglie freno GALFER sono soluzioni di altissima qualità ottenute grazie a materiali di prima scelta, una lavorazione puntuale, una sofisticata logistica con una grande attenzione ai costi. Il Gruppo Continental Continental rappresenta uno dei principali fornitori mondiali del settore automotive. Come fornitore di sistemi frenanti, sistemi e componenti powertrain e chassis, soluzioni infotainment, elettronica del veicolo, pneumatici ed elastomeri tecnici, il Gruppo dà il proprio attivo contributo per la sicurezza di guida. Con un fatturato di 44 miliardi di Euro nel 2017, Continental attualmente impiega più di 238.000 persone in 61 Paesi.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.